SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: Ted Downs who wrote (636)6/11/1999 12:09:00 PM
From: Drapeau  Read Replies (1) | Respond to of 783
 
BioChem Pharma announces agreement in principle to purchase 8
million BioChem common shares from Glaxo Wellcome Inc.

biz.yahoo.com



To: Ted Downs who wrote (636)6/11/1999 1:32:00 PM
From: JDN  Respond to of 783
 
Dear Ted: That was basically the thrust of their message in the annual report. Seems like a good move to me so long as they have growing royalties to offsett the cost of setting up the sales and marketing organization and continued pipeline to have new products to insert into it. JDN


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News